Fact Sheet | 23 Pages
Emergency Use Authorization of Bamlanivimab for COVID-19 | 3 Pages
Autorización de uso de emergencia de bamlanivimab para la enfermedad por COVID-19 | 3 Pages
FDA Letter of Authorization | 35 Pages
What to Expect during a COVID-19 Neutralizing Antibody Treatment Infusion | 8 Pages
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19 | 9 Pages
Allocation Flow in the U.S. | 1 Page
What You Need to Know about Bamlanivimab | 7 Pages
